<DOC>
	<DOCNO>NCT00092755</DOCNO>
	<brief_summary>This study conduct assess safety tolerability investigational drug evaluate effectiveness treatment osteoarthritis hip knee men woman .</brief_summary>
	<brief_title>An Investigational Drug Patients With Osteoarthritis ( 0663-073 )</brief_title>
	<detailed_description>The duration treatment 12 week .</detailed_description>
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Etoricoxib</mesh_term>
	<mesh_term>Ibuprofen</mesh_term>
	<criteria>Patients osteoarthritis hip knee use current approve medication ( nonsteroidal antiinflammatory drug ( NSAIDs ) ) tylenol treat symptom osteoarthritis . Patients take NSAIDs require discontinue use drug symptom must become bad . Patients certain medical condition may allow participate . These condition review study physician .</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2017</verification_date>
	<keyword>Arcoxia</keyword>
</DOC>